CAN WE PREDICT THE BENEFIT OF 70-GENES SIGNATURE IN THE CHOICE OF ADJIUVANT SYSTEMIC TREATMENT FOR ER POSITIVE\HER 2 NEGATIVE TUMOURS IN DAILY PRACTICE ? A SINGLE INSTITUTION EXPERIENCE
Abstract
Publication Date:
2011
Iris type:
4.2 Abstract in Atti di convegno
List of contributors:
Tinterri, C
Published in: